Author:
Giménez-Giner Sara,Llopis-Alemany Antoni,Porta-Oltra Begoña,Llopis-Salvia Pilar,Climente-Martí Mónica,Martínez-Gómez María Amparo
Reference30 articles.
1. Agencia Española de Medicamentos y Productos Sanitarios (AEMPS). Data sheet; 2020. Available at: https://cima.aemps.es/cima/pdfs/es/ft/74304/FT_74304.pdf [accessed 01.01.22].
2. Population pharmacokinetics and dosing regimen optimization of meropenem in cerebrospinal fluid and plasma in patients with meningitis after neurosurgery;Lu;Antimicrob Agents Chemother,2016
3. Pharmacokinetic and pharmacodynamic efficacies of continuous versus intermittent administration of meropenem in patients with severe sepsis and septic shock: a prospective randomized pilot study;Zhao;Chin Med J (Engl),2017
4. DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam anti- biotic doses sufficient for critically ill patients?;Roberts;Clin Infect Dis,2014
5. The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters; 2021. Available at: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_11.0_Breakpoint_Tables.pdf [accessed 01.03.22].